ATGGF (Actinogen Medical) Beginning Cash Position : $5.99 Mil (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Actinogen Medical Beginning Cash Position?

Actinogen Medical's Beginning Cash Position for the quarter that ended in Dec. 2024 was $5.99 Mil.

Actinogen Medical's quarterly Beginning Cash Position increased from Dec. 2023 ($5.66 Mil) to Jun. 2024 ($7.62 Mil) but then declined from Jun. 2024 ($7.62 Mil) to Dec. 2024 ($5.99 Mil).

Actinogen Medical's annual Beginning Cash Position increased from Jun. 2022 ($9.46 Mil) to Jun. 2023 ($10.99 Mil) but then declined from Jun. 2023 ($10.99 Mil) to Jun. 2024 ($5.62 Mil).

Actinogen Medical Beginning Cash Position Historical Data

The historical data trend for Actinogen Medical's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actinogen Medical Beginning Cash Position Chart

Actinogen Medical Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Beginning Cash Position

Get a 7-Day Free Trial

5.27

3.85

9.46

10.99

5.62

Actinogen Medical Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Beginning Cash Position	Get a 7-Day Free Trial															11.05	9.77	5.66	7.62	5.99

Actinogen Medical Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Actinogen Medical Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Actinogen Medical's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Actinogen Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actinogen Medical Ltd (OTCPK:ATGGF) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

3AC:Germany ACW:Australia

Address

109 Pitt Street, Level 9, Suite 901, Sydney, NSW, AUS, 2000

Website

https://www.actinogen.com.au

Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. It is focused on the clinical development of Xanamem, an oral medication for neurological diseases amenable to its mechanism of lowering cortisol in brain cells. Geographically, the company's income is derived in Australia.